Operating Lease, Payments in USD of HTG MOLECULAR DIAGNOSTICS, INC from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly/annual Operating Lease, Payments history and change rate from Q1 2019 to Q1 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Operating Lease, Payments for the quarter ending 31 Mar 2023 was $130K, a 10.5% increase year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Operating Lease, Payments for 2022 was $488K, a 5.21% decline from 2021.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Operating Lease, Payments for 2021 was $514K, a 41.8% decline from 2020.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Operating Lease, Payments for 2020 was $883K, a 14.6% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $130K +$12.4K +10.5% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q1 2022 $118K -$54.1K -31.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q1 2021 $172K -$46.5K -21.3% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q1 2020 $219K +$82.4K +60.4% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q1 2019 $136K 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020

HTG MOLECULAR DIAGNOSTICS, INC Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $488K -$26.8K -5.21% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 $514K -$369K -41.8% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $883K +$113K +14.6% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 $771K 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.